For all people presenting for PEP following a sexual exposure, refer to Table 4.

Although a two-week PEP visit is not generally recommended following sexual exposures, an approximately 5% prevalence of new infections has been reported at two weeks, which were not detected on baseline testing.^80,81

The following recommendations regarding STI testing are recommended for those presenting for PEP:

• asymptomatic patients should be tested for gonorrhoea and chlamydia at site(s) of sexual exposure
• asymptomatic MSM, should have three-site testing of first pass urine, anorectum and pharynx as per national guidelines 
• some trans and gender-diverse patients may be at increased risk of STIs, especially if they have sex with MSM and three-site testing should be offered as per national guidelines
• patients should also be advised to re-present if they experience any anogenital symptoms such as dysuria, abnormal anogenital discharge, anal discomfort (including itch, pain, bleeding) or anogenital ulcers 
• if STI symptoms are present at the time of initiation of PEP, further tests, empirical treatment, and follow-up are required. 

For further advice, refer to the Australian STI Management Guidelines for Use in Primary Care